Skip to search formSkip to main contentSkip to account menu

Concerta

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background Observational studies of switching from branded to generic formulations of the same drug substance often lack… 
2016
2016
Treatment effectiveness between equivalent doses of non-OROS (osmotic controlled release oral delivery system) methylphenidate ER… 
2012
2012
The Netherlands Pharmacovigilance Centre Lareb maintainsthe spontaneous adverse drug reaction (ADR) reportingsystem in the… 
2011
2011
Objective: The main aim of this study was to examine the efficacy, tolerability, and compliance of an extended-release… 
2010
2010
A 14-year-old girl with suicidal ideation was presented to the paediatric hospital about 2 h after ingestion of 21 long-acting… 
2009
2009
Attention-deficit/hyperactivity disorder may have substantial impact on family life, peer interactions, and quality of life… 
2009
2009
The purification of p-hydroxybenzylglucosinolate (sinalbin) on a multigram scale from a crude aqueous extract of white mustard… 
2005
2005
AimThe aim of this study was to assess the impact of switching from immediate-release (IR) methylphenidate (MPH) to OROS® MPH… 
2002
2002
Summary Stimulant therapy is the mainstay of treatment for children, adolescents and adults with attention-deficit/hyperactivity… 
2002
2002
The treatment of substance-abusing adolescents who have comorbid attention-deficit/hyperactivity disorder (ADHD) involves the…